Skip to main content
Erschienen in: Neurocritical Care 1/2015

01.02.2015 | Translational Research

Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage

verfasst von: Anne Brücken, Pinar Kurnaz, Christian Bleilevens, Matthias Derwall, Joachim Weis, Kay Nolte, Rolf Rossaint, Michael Fries

Erschienen in: Neurocritical Care | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Argon at a dosage of 70 % is neuroprotective, when given 1 h after cardiac arrest (CA) in rats. We investigated if a neuroprotective effect of argon would also be observed, when administration was delayed.

Methods

Twenty-four male Sprague–Dawley rats, weighing between 400 and 500 g were subjected to 7 min of CA and 3 min of cardiopulmonary resuscitation. Animals were randomized to receive either 1 h of 70 % argon ventilation 1 h (n = 8) or 3 h (n = 8) after return of spontaneous circulation or no argon treatment (n = 8). For all animals, a neurological deficit score (NDS) was calculated daily for 7 days following the experiment. On day 8, rats were re-anesthetized and transcardially perfused before brains were harvested for histopathological analyses.

Results

All animals survived. Control animals exhibited severe neurologic dysfunction at all time points as measured with the NDS. Argon-treated animals showed significant improvements in the NDS through all postoperative days, even when argon administration was delayed for 3 h. This was paralleled by a significant reduction in the neuronal damage index in the neocortex and the hippocampal CA 3/4 region in argon-treated animals, regardless of the timing of argon administration. However, animals of the delayed argon administration group additionally showed significant reductions in the basal ganglia in comparison with control animals.

Conclusion

Our study demonstrates that a 1-h application of argon provided a significant reduction in histopathological damage, associated with a marked improvement in functional neurologic recovery even when treatment was delayed for 3 h. This is highly significant with regard to clinical situations, where argon treatment cannot be provided timely.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med. 2008;36:588–95.PubMedCrossRef Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med. 2008;36:588–95.PubMedCrossRef
2.
Zurück zum Zitat Dingley J, Tooley J, Porter H, Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke. 2006;37:501–6.PubMedCrossRef Dingley J, Tooley J, Porter H, Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke. 2006;37:501–6.PubMedCrossRef
3.
Zurück zum Zitat Luo Y, Ma D, Ieong E, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology. 2008;109:782–9.PubMedCrossRef Luo Y, Ma D, Ieong E, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology. 2008;109:782–9.PubMedCrossRef
4.
Zurück zum Zitat Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the ‘inert’ gas, xenon. Br J Anaesth. 2002;89:739–46.PubMedCrossRef Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the ‘inert’ gas, xenon. Br J Anaesth. 2002;89:739–46.PubMedCrossRef
5.
Zurück zum Zitat Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology. 2005;102:929–36.PubMedCrossRef Schmidt M, Marx T, Gloggl E, Reinelt H, Schirmer U. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology. 2005;102:929–36.PubMedCrossRef
6.
Zurück zum Zitat Fries M, Nolte KW, Coburn M, et al. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med. 2008;36:2420–6.PubMedCrossRef Fries M, Nolte KW, Coburn M, et al. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med. 2008;36:2420–6.PubMedCrossRef
7.
Zurück zum Zitat Fries M, Brücken A, Cizen A, et al. Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs. Crit Care Med. 2012;40:1297–303.PubMedCrossRef Fries M, Brücken A, Cizen A, et al. Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs. Crit Care Med. 2012;40:1297–303.PubMedCrossRef
8.
Zurück zum Zitat Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M. Xenon: recent developments and future perspectives. Minerva Anestesiol. 2009;75:37–45.PubMed Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M. Xenon: recent developments and future perspectives. Minerva Anestesiol. 2009;75:37–45.PubMed
9.
Zurück zum Zitat Arola OJ, Laitio RM, Roine RO, et al. Feasibility and cardiac safety of inhaled xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest. Crit Care Med. 2013;41:2116–24.PubMedCrossRef Arola OJ, Laitio RM, Roine RO, et al. Feasibility and cardiac safety of inhaled xenon in combination with therapeutic hypothermia following out-of-hospital cardiac arrest. Crit Care Med. 2013;41:2116–24.PubMedCrossRef
10.
Zurück zum Zitat Yarin YM, Amarjargal N, Fuchs J, et al. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat’s organ of Corti. Hear Res. 2005;201:1–9.PubMedCrossRef Yarin YM, Amarjargal N, Fuchs J, et al. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat’s organ of Corti. Hear Res. 2005;201:1–9.PubMedCrossRef
11.
Zurück zum Zitat Loetscher PD, Rossaint J, Rossaint R, et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care. 2009;13:R206.PubMedCentralPubMedCrossRef Loetscher PD, Rossaint J, Rossaint R, et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care. 2009;13:R206.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Jawad N, Rizvi M, Gu J, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett. 2009;460:232–6.PubMedCrossRef Jawad N, Rizvi M, Gu J, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett. 2009;460:232–6.PubMedCrossRef
13.
Zurück zum Zitat Ryang YM, Fahlenkamp AV, Rossaint R, et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med. 2011;39:1448–53.PubMedCrossRef Ryang YM, Fahlenkamp AV, Rossaint R, et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med. 2011;39:1448–53.PubMedCrossRef
14.
Zurück zum Zitat Brücken A, Cizen A, Fera C, et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. Br J Anaesth. 2013;110(Suppl 1):i106–12.PubMedCrossRef Brücken A, Cizen A, Fera C, et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. Br J Anaesth. 2013;110(Suppl 1):i106–12.PubMedCrossRef
15.
Zurück zum Zitat Idris AH, Becker LB, Ornato JP, et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Resuscitation. 1996;33:69–84.PubMedCrossRef Idris AH, Becker LB, Ornato JP, et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Resuscitation. 1996;33:69–84.PubMedCrossRef
16.
Zurück zum Zitat Stark RA, Nahrwold ML, Cohen PJ. Blind oral tracheal intubation of rats. J Appl Physiol. 1981;51:1355–6.PubMed Stark RA, Nahrwold ML, Cohen PJ. Blind oral tracheal intubation of rats. J Appl Physiol. 1981;51:1355–6.PubMed
17.
Zurück zum Zitat Neumar RW, Bircher NG, Sim KM, et al. Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation. 1995;29:249–63.PubMedCrossRef Neumar RW, Bircher NG, Sim KM, et al. Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation. 1995;29:249–63.PubMedCrossRef
18.
Zurück zum Zitat Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463:3–33.PubMedCrossRef Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463:3–33.PubMedCrossRef
19.
Zurück zum Zitat Zhuang L, Yang T, Zhao H, Fidalgo A, Vizcaychipi MP, Sanders R, Yu B, Takata M, Johnson M, Ma D. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med. 2012;40:1724–30.PubMedCrossRef Zhuang L, Yang T, Zhao H, Fidalgo A, Vizcaychipi MP, Sanders R, Yu B, Takata M, Johnson M, Ma D. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med. 2012;40:1724–30.PubMedCrossRef
20.
Zurück zum Zitat David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One. 2012;7:e30934.PubMedCentralPubMedCrossRef David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One. 2012;7:e30934.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat David HN, Haelewyn B, Risso JJ, Abraini JH. Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator. Naunyn Schmiedebergs Arch Pharmacol. 2013;386:91–5.PubMedCrossRef David HN, Haelewyn B, Risso JJ, Abraini JH. Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator. Naunyn Schmiedebergs Arch Pharmacol. 2013;386:91–5.PubMedCrossRef
22.
Zurück zum Zitat Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the n-methyl-d-aspartate receptor glycine site. Anesthesiology. 2013;119(5):1137–48.PubMedCrossRef Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the n-methyl-d-aspartate receptor glycine site. Anesthesiology. 2013;119(5):1137–48.PubMedCrossRef
23.
Zurück zum Zitat Brücken A, Kurnaz P, Bleilevens C, et al. Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K-Channel opening. Resuscitation. 2014;85(6):826–32. Brücken A, Kurnaz P, Bleilevens C, et al. Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K-Channel opening. Resuscitation. 2014;85(6):826–32.
24.
Zurück zum Zitat Fahlenkamp AV, Rossaint R, Haase H, et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur J Pharmacol. 2012;674:104–11.PubMedCrossRef Fahlenkamp AV, Rossaint R, Haase H, et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur J Pharmacol. 2012;674:104–11.PubMedCrossRef
25.
Zurück zum Zitat Krapivinsky G, Krapivinsky L, Manasian Y, et al. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron. 2003;40:775–84.PubMedCrossRef Krapivinsky G, Krapivinsky L, Manasian Y, et al. The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron. 2003;40:775–84.PubMedCrossRef
26.
Zurück zum Zitat Soldatov PE, D’Iachenko AI, Pavlov BN, Fedotov AP, Chuguev AP. Survival of laboratory animals in argon-containing hypoxic gaseous environments. Aviakosm Ekolog Med. 1998;32:33–7.PubMed Soldatov PE, D’Iachenko AI, Pavlov BN, Fedotov AP, Chuguev AP. Survival of laboratory animals in argon-containing hypoxic gaseous environments. Aviakosm Ekolog Med. 1998;32:33–7.PubMed
27.
Zurück zum Zitat Antonov AA, Ershova TA. Retention of the skill to perform adaptive bio-control of bioelectrical activity synchronization in the human brain cortex in an argon-nitrogen-oxygen atmosphere with various oxygen content. Aviakosm Ekolog Med. 2009;43:27–31.PubMed Antonov AA, Ershova TA. Retention of the skill to perform adaptive bio-control of bioelectrical activity synchronization in the human brain cortex in an argon-nitrogen-oxygen atmosphere with various oxygen content. Aviakosm Ekolog Med. 2009;43:27–31.PubMed
28.
Zurück zum Zitat Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ. Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg. 2003;96:746–9.PubMedCrossRef Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ. Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg. 2003;96:746–9.PubMedCrossRef
29.
Zurück zum Zitat Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30:2126–8.PubMedCrossRef Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med. 2004;30:2126–8.PubMedCrossRef
30.
Zurück zum Zitat Ristagno G, Fumagalli F, Russo I, et al. Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest. Shock. 2014;41:72–8.PubMedCrossRef Ristagno G, Fumagalli F, Russo I, et al. Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest. Shock. 2014;41:72–8.PubMedCrossRef
Metadaten
Titel
Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage
verfasst von
Anne Brücken
Pinar Kurnaz
Christian Bleilevens
Matthias Derwall
Joachim Weis
Kay Nolte
Rolf Rossaint
Michael Fries
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2015
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-014-0029-1

Weitere Artikel der Ausgabe 1/2015

Neurocritical Care 1/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.